A detailed history of Silicon Valley Capital Partners transactions in Pfizer Inc stock. As of the latest transaction made, Silicon Valley Capital Partners holds 14,540 shares of PFE stock, worth $375,568. This represents 0.05% of its overall portfolio holdings.

Number of Shares
14,540
Previous 14,448 0.64%
Holding current value
$375,568
Previous $404,000 3.96%
% of portfolio
0.05%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $2,548 - $2,887
92 Added 0.64%
14,540 $420,000
Q2 2024

Oct 29, 2024

BUY
$25.26 - $29.6 $311,834 - $365,412
12,345 Added 587.02%
14,448 $404,000
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $828 - $951
32 Added 1.55%
2,103 $58,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $705 - $916
27 Added 1.32%
2,071 $59,000
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $770 - $900
24 Added 1.19%
2,044 $67,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $758 - $877
21 Added 1.05%
2,020 $74,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $787 - $1,025
20 Added 1.01%
1,999 $81,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $82,623 - $107,855
1,979 New
1,979 $101,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $177,372 - $219,787
-3,877 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $160,197 - $237,466
3,877 New
3,877 $229,000
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $198,330 - $224,675
-5,523 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $25,787 - $29,082
-770 Reduced 12.24%
5,523 $200,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $210,626 - $267,830
6,293 New
6,293 $232,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.